TOP1 and neoplasm: This tumor was chosen for study because its deficiency of BRCA118 confers high sensitivity to TOP1 inhibitors19,20 including the PLX038A prodrug15, and because it represents an intracranial tumor model of TNBC metastatic breast cancer21.